The development and manufacture of medical devices is a long, arduous, and cost-intensive task. This is only compounded further if the said device is in intimate contact (topically or internally) with the body. With the advent of 3D printing, costs associated with short-run and bespoke designs and devices has decreased substantially with only a handful of clinical cases being reported and even fewer commercial products realized. Here, we would like to highlight our recent report in the evaluation of medical-grade bioresorbable polymers for 3D printing.